Another group found that the pSTAT1/pSTAT3 ratio in tumor cells at baseline may serve as a useful prognostic predictor in cutaneous melanoma and a predictor of therapeutic effect for IFN-α2b. This evidence concerns the gene IFNA2 and cutaneous melanoma.